Parathyroid Hormone Treatment Increases Fixation of Orthopedic Implants with Gap Healing: A Biomechanical and Histomorphometric Canine Study of Porous Coated Titanium Alloy Implants in Cancellous Bone

[1]  J. Bechtold,et al.  OSSEOINTEGRATION OF IMPLANTS INSERTED PRESSFIT WITH PARATHYROID HORMONE AS ADJUVANT THERAPY , 2010 .

[2]  R. Müller,et al.  Endosseous implant anchorage is critically dependent on mechanostructural determinants of peri‐implant bone trabeculae , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  H. Genant,et al.  Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double‐blind study of 102 postmenopausal women with distal radial fractures , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  G. Watzek,et al.  Age-related efficacy of parathyroid hormone on osseointegration in the rat. , 2009, Clinical oral implants research.

[5]  P. Aspenberg,et al.  Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats , 2009, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[6]  J. Shibli,et al.  Effect of systemic intermittent administration of human parathyroid hormone (rhPTH[1-34]) on the resistance to reverse torque in rabbit tibiae. , 2008, The Journal of oral implantology.

[7]  N. Endo,et al.  Intermittent administration of human parathyroid hormone (1–34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femora , 2008, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[8]  L. Lanyon,et al.  Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice. , 2008, Bone.

[9]  S. Goldstein,et al.  Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. , 2008, Bone.

[10]  P. Aspenberg,et al.  Bisphosphonates can block the deterioration in implant fixation after withdrawal of intermittent doses of parathyroid hormone. , 2008, The Journal of bone and joint surgery. British volume.

[11]  J. Baas.  Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs , 2008, Acta orthopaedica. Supplementum.

[12]  P. Aspenberg,et al.  Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats , 2008, Acta orthopaedica.

[13]  R. Rizzoli,et al.  Defective Implant Osseointegration Under Protein Undernutrition: Prevention by PTH or Pamidronate , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  Tetsuji Yamamoto,et al.  Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. , 2007, Bone.

[15]  R. Jung,et al.  Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material. , 2007, The International journal of oral & maxillofacial implants.

[16]  R. Müller,et al.  Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis. , 2006, Bone.

[17]  T. Einhorn,et al.  Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. , 2005, Bone.

[18]  P. Aspenberg,et al.  Stimulation of implant fixation by parathyroid hormone (1–34)–A histomorphometric comparison of PMMA cement and stainless steel , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[19]  B. Mitlak,et al.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). , 2005, The Journal of bone and joint surgery. American volume.

[20]  J. F. Whitfield,et al.  Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase , 2004, Calcified Tissue International.

[21]  T. Shirota,et al.  Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[22]  B. Chabner,et al.  Commentary on Clinical Safety of Recombinant Human Parathyroid Hormone 1‐34 in the Treatment of Osteoporosis in Men and Postmenopausal Women , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  M. Dalstra,et al.  Parathyroid hormone induces formation of new cancellous bone with substantial mechanical strength at a site where it had disappeared in old rats. , 2002, European journal of endocrinology.

[24]  P. Aspenberg,et al.  Early Effect of Parathyroid Hormone (1–34) on Implant Fixation , 2001, Clinical orthopaedics and related research.

[25]  P. Aspenberg,et al.  Implant fixation enhanced by intermittent treatment with parathyroid hormone. , 2001, The Journal of bone and joint surgery. British volume.

[26]  D. Burr,et al.  Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). , 2001, Bone.

[27]  H. Gundersen,et al.  Efficiency of systematic sampling in histomorphometric bone research illustrated by hydroxyapatite‐coated implants: Optimizing the stereological vertical‐section design , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  P. Aspenberg,et al.  Strong effect of PTH (1-34) on regenerating bone: A time sequence study in rats , 2000, Acta orthopaedica Scandinavica.

[29]  C. Lees,et al.  Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. , 1999, The Journal of clinical endocrinology and metabolism.

[30]  H. Oxlund,et al.  Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  T. Wronski,et al.  Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. , 1999, Bone.

[32]  N. Endo,et al.  Low dose of human PTH(1-34) improved tibial subcortical bone mass without further cortical bone loss in adult intact beagles , 1998, Journal of Bone and Mineral Metabolism.

[33]  S. Boonen,et al.  Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. , 1998, Endocrinology.

[34]  H. Takahashi,et al.  Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. , 1997, Bone.

[35]  R. Boyce,et al.  Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  J. Reeve.  PTH: A future role in the management of osteoporosis? , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  W. Sietsema.  Animal models of cortical porosity. , 1995, Bone.

[38]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[39]  J. Kärrholm,et al.  Does early micromotion of femoral stem prostheses matter? 4-7-year stereoradiographic follow-up of 84 cemented prostheses. , 1994, The Journal of bone and joint surgery. British volume.

[40]  H. Takahashi,et al.  Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. , 1994, Bone.

[41]  J Kärrholm,et al.  Micromotion of femoral stems in total hip arthroplasty. A randomized study of cemented, hydroxyapatite-coated, and porous-coated stems with roentgen stereophotogrammetric analysis. , 1994, The Journal of bone and joint surgery. American volume.

[42]  O. Tørring,et al.  Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. , 1993, Calcified tissue international.

[43]  W H Harris,et al.  Quantification of Implant Micromotion, Strain Shielding, and Bone Resorption With Porous‐Coated Anatomic Medullary Locking Femoral Prostheses , 1992, Clinical orthopaedics and related research.

[44]  E. Budtz-Jørgensen,et al.  A method for preparing and staining histological sections containing titanium implants for light microscopy. , 1989, Stain technology.

[45]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[46]  L. Schweiberer,et al.  Bone regeneration in animals and in man , 1981, Archives of orthopaedic and traumatic surgery.

[47]  大川 豊.  Intermittent administration of human parathyroid hormone (1-34) increases new bone formation on the interface of hydroxyapatite-coated titanium rods implanted into ovariectomized rat femora , 2009 .

[48]  Y. Shimada,et al.  Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. , 2008, Bone.

[49]  P. M. Rozingt.  A finite element analysis of the pushout test : influence of test conditions , 2004 .

[50]  P. Aspenberg,et al.  Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber. A dose-response study. , 2000, The Journal of bone and joint surgery. British volume.

[51]  P. Aspenberg,et al.  Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber , 2000 .

[52]  K. Søballe,et al.  Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. , 1993, Acta orthopaedica Scandinavica. Supplementum.

[53]  P. Rozing,et al.  A finite element analysis of the push-out test: influence of test conditions. , 1992, Journal of biomedical materials research.

[54]  J. Inoue,et al.  Histomorphometric evaluation on ilium of beagle dogs with long term administration of low dose 1–34 H PTH , 1985 .

[55]  L. Schweiberer,et al.  A Contribution to Understanding the Relative Value of Animal Experiments to Human Pathophysiology , 1981 .